81 related articles for article (PubMed ID: 26044919)
1. Decreased 6-Sulfatoxymelatonin Excretion in Male GH-Deficient Children and Adolescents.
Fideleff HL; Fideleff G; Boquete HR; Suárez M; Azaretzky M; Brunetto O
Horm Res Paediatr; 2015; 84(2):88-93. PubMed ID: 26044919
[TBL] [Abstract][Full Text] [Related]
2. Male-female differences in 6-sulfatoxymelatonin excretion in hypopituitary patients.
Fideleff HL; Fideleff G; Boquete HR; Suárez M; Azaretzky M
Arch Endocrinol Metab; 2016 Feb; 60(3):223-30. PubMed ID: 26886086
[TBL] [Abstract][Full Text] [Related]
3. Quantitation of urinary somatomedin-C in children with normal and abnormal growth.
Quattrin T; Albini CH; Vandlen RL; MacGillivray MH
J Clin Endocrinol Metab; 1987 Dec; 65(6):1168-71. PubMed ID: 3680479
[TBL] [Abstract][Full Text] [Related]
4. Comparative results of a 4-year study on cardiovascular parameters, lipid metabolism, body composition and bone mass between untreated and treated adult growth hormone deficient patients.
Fideleff HL; Boquete HR; Stalldecker G; Giaccio AV; Sobrado PG
Growth Horm IGF Res; 2008 Aug; 18(4):318-24. PubMed ID: 18289903
[TBL] [Abstract][Full Text] [Related]
5. High dose recombinant human growth hormone (GH) treatment of GH-deficient patients in puberty increases near-final height: a randomized, multicenter trial. Genentech, Inc., Cooperative Study Group.
Mauras N; Attie KM; Reiter EO; Saenger P; Baptista J
J Clin Endocrinol Metab; 2000 Oct; 85(10):3653-60. PubMed ID: 11061518
[TBL] [Abstract][Full Text] [Related]
6. [Homocysteine levels in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
Szczepańska J; Urban M; Głowińska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):87-92. PubMed ID: 15504311
[TBL] [Abstract][Full Text] [Related]
7. Urinary pyridinium collagen cross-links predict growth performance in children with idiopathic short stature and with growth hormone (GH) deficiency treated with GH. Skeletal metabolism during GH treatment.
Spagnoli A; Branca F; Spadoni GL; Cianfarani S; Pasquino AM; Argirò G; Vitale S; Robins SP; Boscherini B
J Clin Endocrinol Metab; 1996 Oct; 81(10):3589-93. PubMed ID: 8855806
[TBL] [Abstract][Full Text] [Related]
8. Urinary albumin excretion in short children treated with recombinant human growth hormone.
Sasaki H; Takeda N; Kawamura I; Nishida Y; Kikuchi K; Tanaka M
Clin Nephrol; 1996 Jul; 46(1):6-9. PubMed ID: 8832141
[TBL] [Abstract][Full Text] [Related]
9. Circadian variation of growth hormone secretion in normal prepubertal children. Comparison to constitutional growth delay and growth hormone deficiency.
Hermida RC; García L; Ayala DE
J Endocrinol Invest; 1996 May; 19(5):273-83. PubMed ID: 8796335
[TBL] [Abstract][Full Text] [Related]
10. [Left ventricular mass and function in growth hormone deficient children and adolescents before and after one year of recombinant human growth hormone (GH) replacement therapy].
Szczepańska Kostro J; Tołwińska J; Urban M; Głowińska B
Endokrynol Diabetol Chor Przemiany Materii Wieku Rozw; 2004; 10(2):75-80. PubMed ID: 15504309
[TBL] [Abstract][Full Text] [Related]
11. Changes in serum insulin-like growth factor I (IGF-I) and IGF-binding protein-3 levels during growth hormone treatment in prepubertal short children born small for gestational age.
Boguszewski M; Jansson C; Rosberg S; Albertsson-Wikland K
J Clin Endocrinol Metab; 1996 Nov; 81(11):3902-8. PubMed ID: 8923836
[TBL] [Abstract][Full Text] [Related]
12. Gender-related differences in urinary 6-sulfatoxymelatonin levels in obese pubertal individuals.
Fideleff HL; Boquete H; Fideleff G; Albornoz L; Pérez Lloret S; Suarez M; Esquifino AI; Honfi M; Cardinali DP
J Pineal Res; 2006 Apr; 40(3):214-8. PubMed ID: 16499556
[TBL] [Abstract][Full Text] [Related]
13. Impact of overweight on effectiveness of treatment with human growth hormone in growth hormone deficient children: analysis of German KIGS data.
Reinehr T; Bechtold-Dalla Pozza S; Bettendorf M; Doerr HG; Gohlke B; Hauffa BP; Kaspers S; Land C; Mehls O; Schwab KO; Stahnke N; Ranke MB;
Exp Clin Endocrinol Diabetes; 2011 Oct; 119(9):544-8. PubMed ID: 22006181
[TBL] [Abstract][Full Text] [Related]
14. Pooled prolactin measurements in the evaluation of short children.
Shulman DI; Hu CS; Root AW; Bercu BB
J Clin Endocrinol Metab; 1989 Dec; 69(6):1261-7. PubMed ID: 2511222
[TBL] [Abstract][Full Text] [Related]
15. Effect of growth hormone therapy and puberty on bone and body composition in children with idiopathic short stature and growth hormone deficiency.
Högler W; Briody J; Moore B; Lu PW; Cowell CT
Bone; 2005 Nov; 37(5):642-50. PubMed ID: 16139578
[TBL] [Abstract][Full Text] [Related]
16. A 5-year prospective study of growth hormone (GH)-deficient children treated with GH before the age of 3 years. French Serono Study Group.
Rappaport R; Mugnier E; Limoni C; Crosnier H; Czernichow P; Leger J; Limal JM; Rochiccioli P; Soskin S
J Clin Endocrinol Metab; 1997 Feb; 82(2):452-6. PubMed ID: 9024235
[TBL] [Abstract][Full Text] [Related]
17. Continuous infusion versus daily injections of growth hormone (GH) for 4 weeks in GH-deficient patients.
Laursen T; Jørgensen JO; Jakobsen G; Hansen BL; Christiansen JS
J Clin Endocrinol Metab; 1995 Aug; 80(8):2410-8. PubMed ID: 7543114
[TBL] [Abstract][Full Text] [Related]
18. Serum free insulin-like growth factor I (IGF-I), total IGF-I, and IGF-binding protein-3 concentrations in normal children and children with growth hormone deficiency.
Kawai N; Kanzaki S; Takano-Watou S; Tada C; Yamanaka Y; Miyata T; Oka M; Seino Y
J Clin Endocrinol Metab; 1999 Jan; 84(1):82-9. PubMed ID: 9920066
[TBL] [Abstract][Full Text] [Related]
19. Decreased GH dose after the catch-up growth period maintains metabolic outcome in short prepubertal children with and without classic GH deficiency.
Decker R; Albertsson-Wikland K; Kriström B; Halldin M; Dahlgren J
Clin Endocrinol (Oxf); 2012 Sep; 77(3):407-15. PubMed ID: 22417085
[TBL] [Abstract][Full Text] [Related]
20. Continued growth hormone (GH) treatment after final height is necessary to complete somatic development in childhood-onset GH-deficient patients.
Attanasio AF; Shavrikova E; Blum WF; Cromer M; Child CJ; Paskova M; Lebl J; Chipman JJ; Shalet SM;
J Clin Endocrinol Metab; 2004 Oct; 89(10):4857-62. PubMed ID: 15472176
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
